Merck KGaA has shown off data that fueled its $85 million bet on a late-phase treatment for a rare, locally aggressive tumor.

This country research report on Vietnam Primary Cell Culture Market offers comprehensive insights into the market landscape, customer intelligence, and competitive strategies in the Vietnam market.

This country research report on Vietnam Primary Cell Culture Market offers comprehensive insights into the market landscape, customer intelligence, and competitive strategies in the Vietnam market.

Zynyz is the first and only FDA-approved first-line treatment for adult patients with inoperable locally recurrent or ...

Researchers developed a new machine learning method that, given a relevant amino acid sequence, can automatically predict the location of a protein in any human cell line down to the single-cell level ...

Gilead Sciences, Inc. GILD announced positive top-line results from yet another late-stage study on breast cancer drug, ...

SCLC, first-line maintenance therapy with Zepzelca plus Tecentriq led to improvements in PFS and OS versus Tecentriq alone.

A protein located in the wrong part of a cell can contribute to several diseases, such as Alzheimer's, cystic fibrosis, and ...

The FDA granted a first-ever approval for a first-line therapy for anal cancer to the PD-1 inhibitor retifanlimab (Zynyz), ...

Greetings, and welcome to the Brainstorm Cell Therapeutics First Quarter 2025 Conference Call. At this time, all participants ...